Protara Therapeutics (NasdaqGM:TARA) Update / briefing Transcript

Protara Therapeutics (NasdaqGM:TARA) Update / briefing February 24, 2026 08:00 AM ET Company ParticipantsCarla Beckham - Lead Medical Director and Head of Clinical DevelopmentJacqueline Zummo - Chief R&D OfficerJesse Shefferman - Co-Founder, Director, and CEOJustine O'Malley - SVP of Investor Relations and Corporate AffairsNeal Shore - Medical DirectorSwayam Sheth - Equity Research AssociateConference Call ParticipantsAndres Maldonado - Senior Biotechnology Equity Research AnalystCharles Zhu - Managing Dire ...